Search

everythinglearnresearchcommunity

for

Search:↓

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

A 5-year-old girl with McCune-Albright syndrome grew abnormal hair due to the drug tamoxifen.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

Co-trimoxazole may help treat autoimmune diseases.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

TPA is about 50 times more effective at promoting tumors than MZ.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

PPX causes much less hair loss than traditional taxanes.

Ruxolitinib cream may help treat severe hair loss in children.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

5% topical minoxidil improves hair density and quality in monilethrix patients.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.